ReWalk Robotics, a developer of exoskeletons for people with lower-limb disabilities, is seeking to sell nearly 5.6 million ordinary shares, plus more, worth about $6.2 million. Marlborough, Mass.-based ReWalk is also offering more than 4.5 million ordinary shares which are issuable upon the exercise of outstanding warrants, according to a news release. ReWalk is also…
ReStore exo-suit donated by ReWalk to support stroke survivors at Brooks Rehabilitation
The COVID-19 pandemic has brought attention to the need for innovative systems for stroke rehabilitation, said ReWalk Robotics, which donated a ReStore exo-suit to Brooks Rehabilitation.
ReWalk Robotics wins CE Mark for ReStore soft exoskeleton
ReWalk Robotics has won CE Mark clearance in the European Union for its ReStore soft exo-suit designed for use in stroke rehabilitation. The Marlborough, Mass.-based company touted the clearance as the first for a soft exo-suit in the region. The ReStore exo-suit features a soft, garment-like design and is intended to adaptively synchronize with a…
VA extends support of ReWalk Robotics powered exoskeletons
The U.S. Department of Veterans Affairs (VA) in June 2018 revised its national policy for ReWalk Robotics‘ powered exoskeleton for qualifying veterans with spinal cord injuries (SCI). The revision expands access to training program locations among the VA network and private rehabilitation centers throughout the VA’s Veterans Choice Program. The updated policy also includes further…
ReWalk Robotics ReStore soft exoskeleton expands clinical trials
Clinical trials for the ReWalk Robotics ReStore soft exoskeleton are expanding to five research centers in the United States. The centers involved in the ReWalk Robotics ReStore trials include the Shirley Ryan AbilityLab (Chicago), Spaulding Rehabilitation Hospital (Boston), the MossRehab Stroke and Neurological Disease Center (Elkins Park, PA), TIRR Memorial Hermann (Houston), and the Kessler Foundation (East…
ReWalk Robotics Raises $20M to Expand into China
ReWalk Robotics, which develops rigid and soft exoskeletons to help people walk again after injuries and strokes, is expanding into China expand thanks to a $20 million investment from Hong Kong-based Timwell Corporation Limited. ReWalk and Timwell affiliate companies will form a joint venture in China to develop, manufacture and market ReWalk’s exoskeletons in China,…
ReWalk shares slide on Q3 prelim release
ReWalk Robotics today saw shares dip slightly after releasing preliminary financial results for its 3rd quarter despite posting revenues ahead of consensus on Wall Street. The Israel-based company said it expects to post sales of $1.7 million for the 3 months ended Sept. 30, up 21.4% from the $1.4 million the company posted for the…
ReWalk Robotics aims for 2018 release for Restore softsuit robotic exoskeleton
ReWalk Robotics said today it completed all internal processes related to its Restore robotic rehabilitation softsuit exoskeleton and is ready to initiate clinical trials of the device in 2018, with hopes for a commercial launch in the same year. The Restore softsuit is designed to transmit power to key joints in the legs with cable…
ReWalk Robotics touts Harvard-led Restore soft exosuit study
ReWalk Robotics (NSDQ:RWLK) today released results from a study of a soft suit exoskeleton system designed to aid ambulatory stroke patients, touting that the system was able to facilitate normal walking ability in patients. The study was authored by researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering and Boston University, and utilized a prototype that…
ReWalk Robotics inks French distro deal with Harmonie Médical Service
ReWalk Robotics (NSDQ:RWLK) said today it inked an exclusive French distribution deal with Harmonie Médical Service. Through the deal, HMS will operate as sole distributor of the ReWalk exoskeleton systems for individuals with spinal cord injuries in France. The deal includes both the ReWalk Personal and ReWalk Rehabilitation systems for home and clinical use, respectively. “Our partnership…
ReWalk debuts Restore soft-suit exoskeleton prototype
ReWalk Robotics (NSDQ:RWLK) today debuted the prototype of its Restore soft suit exoskeleton designed to aid stroke survivors. The company presented the prototype alongside collaborators from Harvard University’s Wyss Institute for Biologically Inspired Engineering, and said it would focus on the suit as a “core company goal” for the fiscal year. “We are thrilled with the…
ReWalk Robotics slides on Barclays downgrade
Shares in ReWalk Robotics (NSDQ:RWLK) are off nearly 4% today after an analyst with Barclays downgraded the stock, citing “lack of tangible progress” and increased competition from other players in the robot-assisted rehabilitation market. Barclays analyst Matthew Taylor lowered the investment house’s rating on ReWalk from “equal weight” to “underweight” and cut his price target to…
Layoffs ahead for ReWalk Robotics
ReWalk Robotics (NSDQ:RWLK) is reportedly planning to cut its operating expenses by 30% in 2017, a move that’s slated to include layoffs for an unspecified number of workers. The Marlborough, Mass.- and Israel-based company said it aims to meet its goal partially via a “reduction in staffing.” ReWalk had 87 employees as of December 2015, according to…
ReWalk IPO gets $36 million; Corindus gets $26.6; PrecisionHawk gets $10
ReWalk, the Israeli developer of exoskeletons, joins Ekso and Cyberdyne as publicly-traded companies on international stock exchanges. Their IPO sold 3 million shares at $12 per share. The stock then went on to $30! ReWalk Robotics was hoping to raise $50 million by selling 3.4 million shares at $15 but settled for selling only 3…
ReWalk Robotics (prev Argo Med Tech) (IL)
ReWalk exoskeleton in FDA Trials and on ‘Glee’
Artie (a wheel-chair bound character on Glee, the TV musical) walked using Argo Medical Technologies’ ReWalk exoskeleton on the Christmas episode of Glee. FDA trials are underway for the ReWalk which received EU CE Mark certification earlier this year.
Exoskeletons qualify for direct disability compensation in Germany
BARMER announced it will accept a ruling from state courts that made exoskeletons considered as direct disability compensation.
BU, Harvard receive $3M for assistive robotics research
Researchers aim to improve the lives of people with neuro-motor impairments and to help individuals achieve ambitious fitness goals.
Study: chronic use of robotic hand doesn’t remap sense of touch
A new study highlights the importance of electrode placement when implanting sensory arrays for patients using a robotic hand.
Webinar: Manufacturing Success: Five Secrets – November 17
This webinar was presented live on Tuesday, November 17, 2020. Click below to watch it on demand. Cirtronics has convened a panel of experienced executives as they share their secrets on how to introduce complex products to existing manufacturing systems. Moving a product from one production facility to another or bringing a new product…
Robotics investments recap: July 2020
In July 2020, autonomous vehicles, industrial automation, and surgical robots continued to receive funding at steady levels in comparison with the same period last year.
How telehealth could improve next-gen exoskeletons
ReWalk Robotics and the Wyss Institute are exploring how telehealth capabilities, including remote data provision, analysis and therapy, can improve exoskeletons.